Showing results (1-10 of 42) with videos related to
Sort By:
Pageof 5
Thrombosis|January 31, 2012
Variability in the responsiveness to low-dose aspirin: pharmacological and disease-related mechanismsBianca Rocca, Giovanna PetrucciCurrent Vascular Pharmacology|February 8, 2019
Pathophysiology of Thrombosis in Peripheral Artery DiseaseAida Habib, Giovanna Petrucci, Bianca RoccaVascular Pharmacology|October 23, 2016
Aspirin, stroke and drug-drug interactionsNicholas W Russo, Giovanna Petrucci, Bianca RoccaEuropean Cardiology|June 24, 2026
Obesity and Pharmacokinetic Variability: Implications for Cardiovascular TherapeuticsDario Pitocco, Martina Cortelletti, Giovanna Petrucci, et al.Plos One|August 17, 2022
Physiologically based modelling of the antiplatelet effect of aspirin: A tool to characterize drug responsiveness and inform precision dosingAlberto Giaretta, Giovanna Petrucci, Bianca Rocca, et al.Journal of Cellular and Molecular Medicine|August 21, 2019
Aspirin inhibits proliferation and promotes differentiation of neuroblastoma cells via p21Waf1 protein up-regulation and Rb1 pathway modulationGiacomo Pozzoli, Giovanna Petrucci, Pierluigi Navarra, et al.Antioxidants (Basel, Switzerland)|July 27, 2022
Role of Oxidative Stress in the Pathogenesis of Atherothrombotic DiseasesGiovanna Petrucci, Alessandro Rizzi, Duaa Hatem, et al.Research and Practice in Thrombosis and Haemostasis|March 27, 2020
Increased von Willebrand factor levels in polycythemia vera and phenotypic differences with essential thrombocythemiaMonica Sacco, Paola Ranalli, Stefano Lancellotti, et al.Clinical Laboratory|March 8, 2014
Stability of urinary thromboxane A2 metabolites and adaptation of the extraction method to small urine volumeFrancesca Pagliaccia, Aida Habib, Dario Pitocco, et al.Blood|March 23, 2007
Different STAT-3 and STAT-5 phosphorylation discriminates among Ph-negative chronic myeloproliferative diseases and is independent of the V617F JAK-2 mutationLuciana Teofili, Maurizio Martini, Tonia Cenci, et al.Pageof 5